Eltek (NASDAQ:ELTK), an Israeli manufacturer of technologically advanced printed circuit boards primarily serving defense, medical and industrial applications, on Monday reported full-year 2025 revenue of $51.8 million, an increase of 11% from the prior year.
American Express Global Business Travel (NYSE:GBTG) reported a transformative fourth quarter on Monday, as the integration of recent acquisition CWT propelled revenue up 34% to $792 million.
AbbVie (NYSE:ABBV) shares are in focus after the biopharmaceutical giant released positive topline results for its investigational obesity treatment, ABBV-295.
Sharplink (NASDAQ:SBET) reported full-year 2025 financial and operating results on Monday, marking the completion of its strategic transformation into one of the world's largest corporate holders of Ether (ETH).
Jet.AI (NASDAQ:JTAI) transitioned to profitability in 2025 as the company aggressively shifted its focus from private aviation services toward hyperscale AI data center development.
YY Group Holding (NASDAQ:YYGH), a Singapore-based provider of on-demand staffing and integrated facility management services, on Monday released preliminary, unaudited financial results for the full year ended December 31, 2025, estimating revenue in the range of $57 million to $58 million, representing year-over-year growth of approximately 38.7% to 41.1%.
Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) reported a fourth-quarter loss that was narrower than analysts anticipated, bolstered by a significant cash injection and clinical progress in its high-priority obesity and oncology programs.
Nayax (NASDAQ:NYAX) reported fourth-quarter earnings on Monday that cleared Wall Street’s profitability hurdles, even as revenue narrowly missed consensus estimates.
ZIM Integrated Shipping Services (NYSE:ZIM) reported fourth-quarter earnings on Monday that signaled a recovery in the global container market, bolstered by a strategic shift toward more fuel-efficient vessels.
W&T Offshore (NYSE:WTI) reported a fourth-quarter loss on Monday, reflecting the impact of a volatile commodity price environment even as the company successfully boosted output in the Gulf of Mexico.
FuelCell Energy (NASDAQ:FCEL) shares traded lower on Monday after the company’s first-quarter revenue failed to meet market expectations, highlighting the uneven pace of the global energy transition.
Editas Medicine (NASDAQ:EDIT) reported fourth-quarter results on Monday that significantly outpaced Wall Street projections, fueled by higher collaboration revenue and a sharp reduction in operating expenses.
